Recipient clinical risk factors predominate in possible transfusion‐related acute lung injury
Pearl Toy(University of California, San Francisco), Mark R. Looney(University of California, San Francisco), Nora V. Hirschler(University of California, San Francisco), Barbara Grimes(University of California, San Francisco), Rosa Sanchez Rosen(University of California, San Francisco), Jeffrey L. Winters(Mayo Clinic), Philip J. Norris(University of California, San Francisco), Michael A. Matthay(University of California, San Francisco), Peter Bacchetti(University of California, San Francisco), Michael A. Gropper(University of California, San Francisco), Gregory Wilson(The Coordinating Center), Manish J. Gandhi(Mayo Clinic), Monique Koenigsberg(University of California, San Francisco), Rolf D. Hubmayr(Mayo Clinic), Deanna C. Lee(University of California, San Francisco), Clifford A. Lowell(University of California, San Francisco), Ognjen Gajic(Mayo Clinic), David Mair(American Red Cross), Randy M. Schuller(American Red Cross), Edward L. Murphy(University of California, San Francisco)
Cited by 47
Related Papers
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome
|New England Journal of Medicine|2002|898
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis
|Nature Communications|2020|780
Age Affects Outcomes in Chronic Kidney Disease
|Journal of the American Society of Nephrology|2007|749